Drug profile · INN
atazanavir sulfate
REYATAZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
atazanavir sulfate (REYATAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN atazanavir sulfate
Brand REYATAZ
Route ORAL
Formulation CAPSULE
ATC code J05AE08
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is atazanavir sulfate?
atazanavir sulfate (REYATAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for atazanavir sulfate?
REYATAZ is a marketed brand name for atazanavir sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of atazanavir sulfate?
atazanavir sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.